Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma - a 10 years experience
Pakistan Journal of Medical Sciences. 2016; 32 (6): 1408-1413
in En
| IMEMR
| ID: emr-184966
Responsible library:
EMRO
ABSTRACT
Objective:
To determine the outcome of patients with early-stage [stage I-II] favorable risk classical Hodgkin lymphoma treated with chemotherapy alone or combined modality treatment [CMT] utilizing chemotherapy and involved field radiotherapy
Search on Google
Index:
IMEMR
Language:
En
Journal:
Pak. J. Med. Sci.
Year:
2016